TOLL FREE
SURVIVOR LINE
877-937-7478

MISSION: To provide resources, information, support, and HOPE to all those who are affected by advanced or metastatic cancer.

Survivor Line

FRIENDS for the Journey

Cancer Type

If Cancer Spreads

Cover for Say YES to HOPE

10,674

Say YES to HOPE

Say YES to HOPE

To provide information, resources, support, and HOPE to those affected by advanced cancer or cancer that has spread to the liver from the original cancer

Say YES to HOPE

10 hours ago

Suzanne Martin is a long-term survivor of metastatic colorectal cancer that has spread to her LIVER. It is so wonderful to be able to share her inspiring story during this Interventional Radiology Awareness Week. She is a huge supporter of multidisciplinary care and especially of SIR-Spheres microspheres, which is provided by an interventional radiologist. Watch her powerful story!youtu.be/HUxyQGCPb2I#SayYEStoHope #BeatLiverTumors #AdvancedCancer #changetheworld #LiverCancer #livertumors #hope #multidisciplinarytreatmentteam #surgeon #MedicalOncologist #radiationoncologist #interventionalradiologist ... See MoreSee Less

Suzanne Martin, Colorectal Cancer Survivor

youtu.be

Suzanne Martin, Stage 4 Colorectal Cancer Survivor, is an amazing advocate who shares her story of hope and the importance of a multidisciplinary treatment t...

View on Facebook

Say YES to HOPE updated their status.

5 days ago

This content isn't available right now

When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.

View on Facebook

Say YES to HOPE

2 weeks ago

There are two exciting updates for metastatic colorectal cancer patients related to FRUZAQLA® (fruquintinib).As of 10/1/25, FRUZAQLA® (fruquintinib) is covered at Cigna Healthcare*+. Additionally, as of 7/1/25, FRUZAQLA® (fruquintinib) has been covered on CVS Caremark National Template Formularies. These updates mean that most commercial patients will have more rapid access to FRUZAQLA and a lower co-pay.This also means that ~95% of commercial lives are now covered for FRUZAQLA.The hope is that these formulary updates help improve patient access and time to treatment start for FRUZAQLA.For patients with commercial insurance who are concerned about out-of-pocket costs, the Takeda Oncology Co-Pay Assistance Program may be able to help reduce the out-of-pocket costs associated with FRUZAQLA. Terms and Conditions Apply. For more information, visit www.takedaoncologycopay.com/#metastaticcolorectalcancer #SayYEStoHope #ifcancerspreads #options #oraltreatment #Takeda #insurance #thereishope ... See MoreSee Less

www.takedaoncologycopay.com

View on Facebook

Say YES to HOPE updated their status.

2 weeks ago

This content isn't available right now

When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.

View on Facebook

Say YES to HOPE

2 weeks ago

Secure Your Spot for Nov 5th - Live National Webinar With Q&A - Register Today!

primeinc.org

Join leading experts in oncology and pathology for an engaging discussion on the latest strategies for diagnosing and managing HER2-low and...

View on Facebook

TREATMENT
TEAM

BIOMARKERS
AND GENETIC
TESTING

CARE
PLAN

CLINICAL
TRIALS

IMMUNO-
ONCOLOGY

Featured Stories of HOPE